AESTHETIC & IMPLANT SEMINARS LTDActive

Company number 08017001Private limited companyIncorporated 2012

Key figures

£135,407-17.1%
Net assets 2024/25
-100 k0100 k200 k300 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, AESTHETIC & IMPLANT SEMINARS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand249,153360,057525,438307,975184,003
Total assets283,639385,615554,094323,740193,218
Total liabilities269,277131,969320,282179,33574,312
Net assets / total equity45,597266,517259,131163,334135,407
Average number of employees11245

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: AESTHETIC & IMPLANT SEMINARS LTD

Company

AESTHETIC & IMPLANT SEMINARS LTD is a private limited company registered with Companies House under company number 08017001. It was incorporated on 3 Apr 2012. Its status is active. The registered office is in Leamington spa (CV32). Its nature of business (SIC 2007) is post-graduate level higher education (85422).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files small company accounts (filleted). Net assets were £135,407, down 17.1% on the previous year. Cash at bank and in hand was £184,003. Total assets were £193,218 and total liabilities £74,312. The company had an average of 5 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 17 Apr 2027.